Bill > HB1881

This bill amends Missouri law to add xylazine to Schedule III of the controlled substances list, meaning it is recognized for medical use but has a lower potential for abuse than substances in Schedules I and II, and its abuse may lead to moderate or low physical dependence or high psychological dependence. The bill specifies exceptions for xylazine when it is prescribed, dispensed, or administered to animals under specific federal regulations, or when it is manufactured, distributed, or used as an active pharmaceutical ingredient for approved animal drugs or for pharmaceutical compounding by licensed professionals. This action is significant because xylazine, a veterinary sedative, has increasingly been found mixed with illicit drugs like fentanyl, posing additional health risks to users.